Quick Takeaways
- PRICE T ROWE ASSOCIATES INC /MD/ filed SCHEDULE 13G/A for IGM BIOSCIENCES INC COMMON STOCK (IGMS).
- Disclosed ownership: 10%.
- Date of event: 31 Dec 2024.
PRICE T ROWE ASSOCIATES INC /MD/ - 31 Dec 2024 SCHEDULE 13G/A Report for IGM BIOSCIENCES INC COMMON STOCK (IGMS)
- Filing Manager
- PRICE T ROWE ASSOCIATES INC /MD/
- Reporting Manager
- T. Rowe Price Associates, Inc.
- Security
- IGM BIOSCIENCES INC COMMON STOCK
- Symbol
- IGMS
- Shares outstanding
- 33,990,467 shares
- Disclosed Ownership
- 3,568,999 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 09:44:10 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 07 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"PRICE T ROWE ASSOCIATES INC /MD/ disclosed 10% ownership in IGM BIOSCIENCES INC COMMON STOCK (IGMS) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 09:44.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Associates, Inc. | 10% | 3,568,999 | 3,488,741 | 0 | Ellen York | Vice President |